In the second study, EBV-specific effector CD8 T cells were higher in number in RA patients (n = 25) than in control individuals (n = 20), but this study concerned a low number of patients and was only cross-sectional [26]. The gene discussed is CD8A; the disease is rheumatoid arthritis.